Merckle may have to sell Ratiopharm -sources


FRANKFURT, Dec 27 (Reuters) - German tycoon Adolf Merckle might have to sell his generic drugs maker Ratiopharm as part of a broader financial rescue package agreed with creditor banks, two sources close to the matter told Reuters on Saturday. It would boil down to a sale of Ratiopharm, one of the sources said. German newspaper Suedwest Presse had reported on its website on Friday that a sale of Ratiopharm was likely and was probably unavoidable, citing the head of Ratiopharm's work ...

Premium Content (PAID Subscription Required)

"Merckle may have to sell Ratiopharm -sources" is part of the paid WardsAuto Premium content. You must log in with Premium credentials in order to access this article. Premium paid subscribers also gain access to:

  All of WardsAuto's reliable, in-depth industry reporting and analysis
  Hundreds of downloadable data tables including:
  •   Global sales and production data by country
  •   U.S. model-line inventory data
  •   Engine and equipment installation rates
  •   WardsAuto's North America Plant by Platform forecast
  •   Product Cycle chart
  •   Interrelationships among major OEMs
  •   Medium- and heavy-duty truck volumes
   •  Historical data and much more!

For pricing and subscription information please contact
Lisa Williamson by email: or phone: (248) 799-2642

Current subscribers, please login or CLICK for support information.

Already registered? here.

Jan 18, 2018

2018 Wards 10 Best Engines Editorial Roundtable Part 2

WardsAuto editors discuss some of the 22 nominees that did not make the cut in this year's Wards 10 Best Engines competition....More


Follow Us

Sponsored Introduction Continue on to (or wait seconds) ×